Last additions - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Myopic CNVM Left Eye125 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye136 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye153 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye161 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye149 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye173 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye187 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion134 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion135 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion104 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion119 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion105 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion131 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion134 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion121 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion123 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion109 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion131 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion137 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion123 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion121 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion124 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion142 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion110 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion138 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion116 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion105 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion105 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion129 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion101 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion118 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye203 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye135 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye106 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye110 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye150 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye108 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye139 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye147 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye139 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye121 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye109 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye121 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye140 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye160 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye139 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye96 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye88 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye131 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye110 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye126 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye144 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye142 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye132 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye159 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye136 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye144 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye133 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
Large Hyper-reflective drusen in age-related macular degeneration238 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration244 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration219 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration197 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration234 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration231 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration235 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration224 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration243 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Non exudative MNV192 viewsSep 18, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion228 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion213 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion214 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion196 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion203 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion236 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion223 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion216 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion255 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years213 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years236 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years199 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years207 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years198 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years230 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years212 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years196 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years210 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years186 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years196 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years186 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years205 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years195 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years187 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years175 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years216 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years235 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years196 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years236 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years219 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years240 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
| 2694 files on 27 page(s) |
 |
3 | |
|
|
|
|
|
|
|
|
